• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd and depression medication Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies regarding how exposure over time may affect a fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to consider the benefits of taking it against the potential dangers for the baby. Physicians don't have the information needed to give clear guidelines, but they can provide information about benefits and risks that can assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at greater risk of fetal malformations or structural birth defects. Researchers conducted a massive population-based study of case control to examine the prevalence of major structural defects in infants born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to confirm that the classification was correct and to eliminate any bias.

However, the study had its limitations. Researchers were unable, in the first place to distinguish the effects caused by the medication from the disorder. This limitation makes it difficult to determine whether the limited associations observed in the groups that were exposed result from medication for inattentive adhd and anxiety use or the confounding effect of comorbidities. In addition the study did not study the long-term outcomes of offspring.

The study revealed that babies whose mothers took ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not take any medication during pregnancy or stopped taking their medication before or during pregnancy. This was due to central nervous system disorders, and the increased risk of admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant private adhd assessment medway medication during pregnancy also had an elevated chance of having a caesarean delivery or having a baby born with a low Apgar score (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, where possible, assist them in developing strategies to improve their coping abilities that can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or end treatment during pregnancy is a question that more and more doctors confront. The majority of these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors must weigh what is the most common adhd medication prescribed they know, the experiences of other doctors, and what research suggests on the subject as well as their own judgments for each individual patient.

The issue of potential risks to the infant can be difficult to determine. Many of the studies on this topic are based on observational data rather than controlled research, and their findings are often contradictory. Most studies limit their analysis to live births, which can underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these issues by analyzing both information on deceased and live births.

The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no connection and the majority of studies have a neutral or slight negative effect. As a result an accurate risk-benefit analysis must be conducted in every situation.

For many women with ADHD, the decision to discontinue medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. A decrease in medication could also impact the ability to safely drive and to perform work-related tasks which are vital aspects of normal life for those with ADHD.

She suggests that women who aren't sure whether to take the medication or discontinue it due to pregnancy, educate their family members, coworkers and acquaintances about the condition, its impact on daily functioning and the advantages of staying on the current treatment regimen. It can also make the woman feel more comfortable when she is struggling with her decision. It is important to remember that certain drugs can pass through the placenta, so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug could be transferred to the infant.

Birth Defects and Risk of

As the use and use of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the possible effects of the drugs on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers used two massive data sets to study over 4.3 million pregnancy and determine if stimulant medication use increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester Adhd Medication Making It Worse medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The authors of the study found no association between early use of medication and congenital abnormalities like facial clefting, or club foot. The results are in line with previous studies that have shown an increase, but not significant, in the risk of heart malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. The risk increased in the latter stages of pregnancy when a large number of women decided to stop taking their medication.

Women who were taking ADHD medication during the first trimester were more likely require a caesarean birth, have an insufficient Apgar after delivery and have a baby that needed help breathing when they were born. However the researchers of the study were unable to eliminate selection bias by restricting the study to women who did not have other medical issues that could have contributed to these findings.

The researchers hope their study will serve to inform the clinical decisions of physicians who encounter pregnant women. They suggest that although a discussion of risks and benefits is important however, the decision to stop or maintain medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also advise that, while stopping the medication is an option, it isn't an option to consider due to the high prevalence of depression and other mental health issues for women who are expecting or recently postpartum. Additionally, research suggests that women who stop taking their medication will have a harder adjustment to life without them after the baby is born.

Nursing

The responsibilities of being a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending doctor appointments as well as getting ready for the arrival of a child and adapting to new routines in the home are often faced with a number of difficulties. Therefore, many women decide to continue taking their adhd and depression medication medications throughout pregnancy.

The majority of stimulant medicines are absorbed through breast milk in small amounts, therefore the risk to the breastfeeding infant is minimal. The rate of exposure to medication will vary based on the dosage, frequency of administration and the time of the day. Additionally, different medications enter the baby’s system through the gastrointestinal tract or through breast milk. The effect on a newborn's health is not completely understood.

Because of the lack of research, some physicians might be tempted to stop taking stimulant medications during the course of pregnancy. This is a difficult decision for the patient, who must weigh the benefits of keeping her medication against the potential dangers to the embryo. Until more information becomes available, GPs can inquire about pregnant patients whether they have a background of ADHD or if they intend to take medication during the perinatal stage.

Numerous studies have proven that women can continue taking their ADHD medication in a safe manner during pregnancy and breast-feeding. In the end, an increasing number of patients choose to do so and, in consultation with their doctor they have discovered that the benefits of keeping their current medication outweigh any risks.

Women with ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder and learn about treatment options and strengthen existing strategies for managing. This should be a multidisciplinary approach together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, monitoring of signs of deterioration and, if necessary adjustments to the medication regimen.